Systemic inflammation is an independent predictive marker of clinical outcomes in mucosal squamous cell carcinoma of the head and neck in oropharyngeal and non-oropharyngeal patients.
about
T cell abundance in blood predicts acute organ toxicity in chemoradiotherapy for head and neck cancer.Impact of hematological inflammatory markers on clinical outcome in patients with salivary duct carcinoma: a multi-institutional study in Japan.The use of rapid and cost-effective blood-based biomarkers in combination with tumour TNM stage for individual head and neck cancer patient treatment selection.Neutrophil-lymphocyte ratio complements volumetric staging as prognostic factor in patients treated with definitive radiotherapy for oropharyngeal cancer.MiR-223-3p inhibits angiogenesis and promotes resistance to cetuximab in head and neck squamous cell carcinomaIdentifying pretreatment baseline factors predictive of distant metastasis in patients with nasopharyngeal carcinoma after radiotherapy.Prognostic role of neutrophil-to-lymphocyte ratio in head and neck cancer: A meta-analysis.Anemia and neutrophil-to-lymphocyte ratio are prognostic in p16-positive oropharyngeal carcinoma treated with concurrent chemoradiation.Pretreatment neutrophil to lymphocyte ratio in determining the prognosis of head and neck cancer: a meta-analysis.DNA methylation derived systemic inflammation indices are associated with head and neck cancer development and survivalOptimal cutoff of pretreatment neutrophil-to-lymphocyte ratio in head and neck cancer patients: a meta-analysis and validation study
P2860
Q37662334-E906BAE6-48F9-4977-85C2-A3CCC5A35329Q37702050-492CD726-52FF-4E9B-BD17-6B49A162FD79Q37710125-D51951AC-7331-4BBD-A902-D956D218A756Q41278675-1D050184-0186-45B4-8BD7-7E6D8FCBF5BFQ41342698-AD22CE8A-E101-4D57-8D4D-FAA6CB47548DQ42267225-031A127B-617A-47C9-AEEB-97255F16A429Q48117100-92C73DAB-6E80-4BDA-AFD8-217FD9408E24Q49660807-C3303637-2831-4250-8B17-8D79A1C5C963Q55279094-5146B43D-22C7-4469-B9EA-4CF7CC39D6CAQ57144581-BB34E118-7E65-46E6-97B3-ECF4641F62E4Q57474616-675225C5-B066-40CD-ACCC-5DCCFCC9983C
P2860
Systemic inflammation is an independent predictive marker of clinical outcomes in mucosal squamous cell carcinoma of the head and neck in oropharyngeal and non-oropharyngeal patients.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Systemic inflammation is an in ...... nd non-oropharyngeal patients.
@ast
Systemic inflammation is an in ...... nd non-oropharyngeal patients.
@en
type
label
Systemic inflammation is an in ...... nd non-oropharyngeal patients.
@ast
Systemic inflammation is an in ...... nd non-oropharyngeal patients.
@en
prefLabel
Systemic inflammation is an in ...... nd non-oropharyngeal patients.
@ast
Systemic inflammation is an in ...... nd non-oropharyngeal patients.
@en
P2093
P2860
P1433
P1476
Systemic inflammation is an in ...... nd non-oropharyngeal patients.
@en
P2093
Alex Guminski
Anthony J Gill
Benjamin D W Harris
Carol R Haddad
David Veivers
Kellie A Charles
Mark Stevens
Michael Back
Stephen J Clarke
Thomas Eade
P2860
P2888
P356
10.1186/S12885-016-2089-4
P407
P577
2016-02-18T00:00:00Z
P5875
P6179
1020655580